Discovery & Innovation
As we previously discussed, CRISPR-mania is sweeping the globe. (Okay, it might not be as big as Beatlemania, but more than a few life science...
It’s a sad story that everyone is familiar with: A patient takes one or more well-known cancer drugs, and they work – for a while. However, after...
Over the course of this series so far we’ve looked at the role of the microbiome in two of the three major therapeutic areas targeted by drug...
The vast majority of compounds that enter clinical trials fail to make it through. The result: few drugs, plenty of bills. The consensus in drug...
Outsourcing has proven to reduce costs while dramatically improving productivity of the drug discovery process. Primary benefits to outsourcing...
Having introduced the age of the microbiome in drug discovery and the microbiome in metabolic disease we now turn to the influence of the...
A fluorescent tag, also known as a label or probe, is a molecule that is chemically attached to a biomolecule such as a protein, antibody, or...
The key to fighting chronic diseases is connecting the multitude of scientific and technological advances to diagnostics and therapeutics. Experts...
How difficult can antibiotic drug discovery be? Some of those struggling with their drug discovery projects in other areas might find themselves...
We previously discussed some of the failures in drug discovery for several chronic diseases. Now, we explore the partnerships that have been...